loading...

SCAR-Q© (SCAR-Q©)

Klassen AF; Mundy LR; Miller C; DiLaura A; Ziolkowski N; Pusic AL

ProQolid

Last update: November 2021

Basic description

  • Published in 2018
Authors

Klassen AF; Mundy LR; Miller C; DiLaura A; Ziolkowski N; Pusic AL

Copyright
Copyright © McMaster University (Hamilton, Canada) and Memorial Sloan Kettering Cancer Center (New York City, USA)
Objective
To evaluate treatments for scars
Therapeutic area
  • Pathological Conditions, Signs and Symptoms
Therapeutic indication

Cicatrix

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English
Translations
32 translation(s)
Bibliographic reference(s) of the original questionnaire

Klassen AF, Ziolkowski N, Mundy LR, Miller C, DiLaura A, Pusic A. Development of a New Patient-Reported Outcome Instrument to Evaluate Treatments for Scars: The SCAR-Q. Plast Reconstr Surg Glob Open. 2018 Apr 24;6(4):e1672 (Full text article)

Ziolkowski N, Pusic AL, Fish J, Mundy LR, Forrest CR, Binhammer P, Hollebeck S, Arriagada C, Greenhalgh D, Klassen AF. Psychometric Findings for the SCAR-Q Patient-Reported Outcome Measure Based on 731 Children and Adults with Surgical, Traumatic and Burn Scars from 4 Countries. Plast Reconstr Surg. 2020 Sep;146(3):331e-338e (PubMed abstract)

Ziolkowski N, Behman R, Klassen AF, Fish JS, Mundy LR, She RW, Forrest CR, Hollenbeck S, Arriagada C, Greenhalgh D, Pusic AL. Determining the independent risk factors for worse SCAR-Q scores and future scar revision surgery. Plast Reconstr Surg. 2021 Jul 1; 148(1):203-212 (PubMed abstract)